This clinical trial is focused on patients with acute coronary syndrome, a condition where the blood supply to the heart is suddenly blocked. The study is investigating the effects of two treatments: a combination of ticagrelor and acetylsalicylic acid (commonly known as aspirin) compared to aspirin alone. The goal is to determine if the combination therapy can improve outcomes for patients who have undergone a specific type of heart surgery called coronary artery bypass grafting (CABG).
Participants in the study will be randomly assigned to receive either the dual therapy of ticagrelor and aspirin or aspirin alone. The study will monitor the participants over a period of 12 months to observe the occurrence of major adverse cardiovascular events, which include serious issues like heart attacks, strokes, or the need for additional heart procedures. The study aims to see if the combination of medications can reduce these events compared to using aspirin alone.
The trial will help to understand whether adding ticagrelor to the standard aspirin treatment can provide better protection against heart-related complications after surgery. This research is important for improving treatment strategies for patients with acute coronary syndrome who have undergone CABG, potentially leading to better long-term health outcomes.



Denmark
Finland
Iceland
Norway
Sweden